


1. Dtxsid60909621
2. 105597-46-4
3. A816762
4. 1-(2-deoxypentofuranosyl)-4-imino-1,4-dihydro-1,3,5-triazin-2-ol
5. 4-azanyl-1-[(4s)-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-1,3,5-triazin-2-one
| Molecular Weight | 228.21 g/mol |
|---|---|
| Molecular Formula | C8H12N4O4 |
| XLogP3 | -1.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 228.08585488 g/mol |
| Monoisotopic Mass | 228.08585488 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 356 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Dacogen |
| PubMed Health | Decitabine (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Dacogen (decitabine) for Injection contains decitabine (5-aza-2-deoxycitidine), an analogue of the natural nucleoside 2-deoxycytidine. Decitabine is a fine, white to almost white powder with the molecular formula of C8H12N4O4 and a mo... |
| Active Ingredient | Decitabine |
| Dosage Form | Injectable |
| Route | Intravenous |
| Strength | 50mg/vial |
| Market Status | Prescription |
| Company | Eisai |
| 2 of 2 | |
|---|---|
| Drug Name | Dacogen |
| PubMed Health | Decitabine (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Dacogen (decitabine) for Injection contains decitabine (5-aza-2-deoxycitidine), an analogue of the natural nucleoside 2-deoxycytidine. Decitabine is a fine, white to almost white powder with the molecular formula of C8H12N4O4 and a mo... |
| Active Ingredient | Decitabine |
| Dosage Form | Injectable |
| Route | Intravenous |
| Strength | 50mg/vial |
| Market Status | Prescription |
| Company | Eisai |